TB Mukt Bharat Abhiyaan

March 23, 2026 3:28 PM

Health Minister J.P. Nadda to lead World TB Day 2026 event, launch ‘TB Mukt Bharat’ 100-days campaign

Union Health Minister Jagat Prakash Nadda will preside over a national-level event on March 24 to mark World Tuberculosis (TB) Day 2026 at Gautam Buddha University in Greater Noida, Uttar Pradesh. The event is aimed at highlighting India’s progress in combating tuberculosis and reinforcing the government’s commitment to achieving a TB-free nation in line with the vision of Prime Minister Narendra Modi. On the occasion, the Health Minister will launch a series of initiatives, including the ...

May 14, 2025 9:54 AM

PM Modi urges intensified, targeted action to achieve a TB-free India

Emphasizing the urgency of focused and accelerated efforts to eliminate tuberculosis (TB), Prime Minister Narendra Modi chaired a high-level review meeting on the National TB Elimination Programme (NTEP) at his official residence. He highlighted the importance of evaluating the status and progress of the NTEP, along with the outcomes of the recently concluded 100-Day TB Mukt Bharat Abhiyaan. The Prime Minister reiterated India’s resolve to eliminate the disease. He emphasized the need to repl...

March 25, 2025 3:07 PM

100-day intensified campaign lays strong foundation to fight TB: PM Modi

The 100-day intensified TB Mukt Bharat Abhiyaan has laid a strong foundation for a tuberculosis-free India, said Prime Minister Narendra Modi on Tuesday. The Prime Minister’s Office said this, in a post shared on X, citing a media article by Union Health Minister JP Nadda. “India’s fight against TB is witnessing remarkable progress. The Union Health Minister JP Nadda shares key insights on the recently concluded 100-day Intensified TB Mukt Bharat Abhiyaan which has set a strong foundatio...

September 16, 2024 3:28 PM

Govt approves revolutionary six-month treatment for drug-resistant TB

The Union Ministry of Health & Family Welfare has approved the introduction of a novel treatment regimen for multidrug-resistant tuberculosis (MDR-TB) under its National TB Elimination Program (NTEP). The new BPaLM regimen, a four-drug combination of Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin, promises to revolutionize MDR-TB treatment in India. This shorter, six-month treatment option is set to replace the traditional 20-month procedure, offering higher success rates with fewer s...